Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Greenphire, a US-based provider of payment technology for the clinical trial industry, has entered into a strategic partnership with ERT, a global leader in high-quality patient safety and efficacy endpoint data collection, to boost patient compliance for global clinical trials.
Subscribe to our email newsletter
The deal will combine Greenphire’s ClinCard System with ERT’s electronic patient reported outcomes (ePRO) technology.
Greenphire vice president of Product Management Kyle Cunningham said by incorporating the company’s ClinCard technology with ERT’s remote collection of ePRO assessments we are able to improve the value of the technologies to its joint clients.
"We know how vital accurate subject self-report data is to a clinical trial. By linking patient reporting to compensation, our clients can now enhance patient engagement between site visits and, consequently, improve compliance," Cunningham said.
The collaboration will allow sponsors and CROs to provide real-time compensation to patients for compliance with study protocols by linking their ePRO activity to a ClinCard personal debit card.
In addition to using Greenphire’s system to compensate participants with stipends for site visits, clients can now customize out-of-office reimbursement for patients’ time and effort based on the specific requirements of each protocol.
ERT executive vice president and chief operating officer Jim Corrigan said the partnership is the next step forward in maximizing patient compliance.
"Patients are a trial’s most valuable asset and by combining ERT and Greenphire’s technology, sponsors and CROs will be able to have a simple, reliable communication link to patients as well as a seamless tool for reimbursing them for their time and expense," Corrigan said.
Greenphire co-founder and CEO Sam Whitaker said the company is happy to be working with ERT on this game-changing partnership.
"ERT has built and deployed more than 100,000 ePRO devices through more than 100 international trials," Whitaker said.
"Their track record speaks for itself and we look forward to providing this combined technology solution to help increase compliance, speed time-to-market, and boost return on investment for our clients who are developing life-saving treatments to meet global health needs."